Business Wire

Alcon Introduces AcrySof IQ PanOptix Trifocal IOL in the U.S., the First and Only FDA-Approved Trifocal Lens

PanOptix delivers an exceptional combination of near, intermediate and distance vision and substantially reduces the need for glasses 1,2 More than ninety-nine percent of PanOptix patients in the FDA ...
Yahoo Finance

Alcon launches new trifocal toric intraocular lens for patients with astigmatism undergoing cataract surgery

BASEL, Switzerland, January 26, 2017 - Alcon, the global leader in eye care and a division of Novartis, announces the launch of AcrySof® IQ PanOptix® Toric presbyopia- and astigmatism-correcting ...
Healio

FDA approves Alcon’s AcrySof IQ PanOptix trifocal IOL

Please provide your email address to receive an email when new articles are posted on . PanOptix, which is already available in more than 70 countries, has been shown to deliver a combination of near, ...
Pharmabiz

Novartis' eye care division Alcon introduces AcrySof IQ PanOptix Toric intraocular lens for patients with astigmatism undergoing cataract surgery

Alcon, the global leader in eye care and a division of Novartis, announces the launch of AcrySof IQ PanOptix Toric presbyopia- and astigmatism-correcting intraocular lens (IOL) for patients with ...
Nasdaq

Alcon Surpasses 175 Million IOLs Implanted Globally

Milestone includes more than 6 million PCIOL implants worldwide, with PanOptix and Vivity leading globally in trifocal and EDOF IOLs1,* PanOptix delivers outstanding patient satisfaction and freedom ...
Nasdaq

Alcon Introduces AcrySof IQ PanOptix Trifocal IOL in the U.S., the First and Only FDA-Approved Trifocal Lens

PanOptix is already one of the leading presbyopia-correcting IOLs in more than 70 countries. It is designed for today’s active lifestyles, from viewing mobile devices and computer screens to ...